Original Article
The relationship between HER2 status acquired from pathological data and metabolic parameters from pre-treatment [18F]FDG PET/CT in gastric adenocarcinomas
Relación entre el estado de HER2 adquirido a partir de los datos patológicos y los parámetros metabólicos obtenidos mediante [18F]FDG PET/TC pretratamiento en adenocarcinomas gástricos
M.N. Acar Tayyara,
,1, M.Ö. Tamama,1, G.B. Babacana,1, M.C. Şahina,1, H. Özçevikb,1, S. Şengiz Erhanc,1, A.E. Öztürkd,e,1
a Department of Nuclear Medicine, University of Health Sciences, Prof. Dr. Cemil Taşcıoğlu City Hospital, Istanbul, Turkey
b Department of Nuclear Medicine, University of Health Sciences, Başaksehir Çam and Sakura City Hospital, Istanbul, Turkey
c Department of Pathology, University of Health Sciences, Prof. Dr. Cemil Taşcıoğlu City Hospital, Istanbul, Turkey
d Department of Medical Oncology, Prof. Dr. Cemil Taşcıoğlu City Hospital, Istanbul, Turkey
e University of Health Sciences, Istanbul, Turkey
